Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23339811 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System
Conditions: Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Interventions: Device: XIENCE V® Everolimus Eluting Coronary Stent;   Device: TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent

Study has passed its completion date and status has not been verified in more than two years.